Drug intelligence / Profile preview

TIMELESS siRNA

Development stage
Unknown
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Intratumoral
01

Overview

TIMELESS siRNA refers to small interfering RNA molecules designed to silence the expression of the *TIMELESS* (TIM) gene. The TIMELESS protein is a highly conserved component of the circadian clock and plays a pivotal role in maintaining genome stability by coordinating DNA replication with the cell cycle and responding to replication stress. In various malignancies, including breast, lung, and colorectal cancers, TIMELESS is frequently overexpressed, where it promotes tumor cell proliferation, survival, and resistance to chemotherapy. By leveraging the RNA interference (RNAi) mechanism, TIMELESS siRNA induces the sequence-specific degradation of TIM mRNA, leading to reduced protein levels. While primarily utilized as a research-use-only (RUO) tool to investigate chronobiology and DNA damage repair pathways, it is also studied in preclinical models as a potential therapeutic strategy to sensitize cancer cells to DNA-damaging agents and inhibit tumor progression.

Other names
TIM siRNAsiRNA targeting TIMELESSTimeless-siRNA
02

Targets

Innate immune RNA sensors

Beyond the preview

Go deeper on TIMELESS siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TIMELESS siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call